D J Hosking
Overview
Explore the profile of D J Hosking including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
1428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reid I, Hosking D
Bone
. 2010 Sep;
49(1):89-94.
PMID: 20832512
Paget's disease is the best example of a common high turnover bone disease. A review of the early use of bisphosphonates in the treatment of this condition shows that many...
2.
Prinsloo P, Hosking D
Ther Clin Risk Manag
. 2008 Mar;
2(3):235-49.
PMID: 18360599
Alendronate is one of the best and most extensively studied bisphosphonates in the treatment of osteoporosis. This review considers in detail the major pivotal study, the fracture intervention trial (FIT),...
3.
Stavroulopoulos A, Cassidy M, Porter C, Hosking D, Roe S
Am J Transplant
. 2007 Oct;
7(11):2546-52.
PMID: 17908281
Vitamin D plays an important role in calcium homeostasis. Renal transplant recipients may be more susceptible to reduced levels because of decreased sun exposure and steroid therapy. This study aimed...
4.
Sahota O, Mundey M, San P, Godber I, Hosking D
Osteoporos Int
. 2006 Apr;
17(7):1013-21.
PMID: 16596461
Introduction: Vitamin D insufficiency is common, however within individuals, not all manifest the biochemical effects of PTH excess. This further extends to patients with established osteoporosis. The mechanism underlying the...
5.
Hosking D, Geusens P, Rizzoli R
QJM
. 2005 May;
98(6):403-13.
PMID: 15879439
A major aim of evidence-based medicine is to assist clinical decision-making by providing the most current and reliable medical information. Systematic reviews and meta-analyses are important tools in this process....
6.
Sahota O, Mundey M, San P, Godber I, Lawson N, Hosking D
Bone
. 2004 Jun;
35(1):312-9.
PMID: 15207772
It is evident from several studies that not all patients with hypovitaminosis D develop secondary hyperparathyroidism. What this means for bone biochemistry and bone mineral density (BMD) remains unclear. The...
7.
Sims R, Hosking D, Cassidy M, Dasgupta I
Clin Nephrol
. 2004 Mar;
61(2):159-60.
PMID: 14989638
No abstract available.
8.
Ralston S, Coleman R, Fraser W, Gallagher S, Hosking D, Iqbal J, et al.
Calcif Tissue Int
. 2003 Oct;
74(1):1-11.
PMID: 14523593
No abstract available.
9.
Hosking D, Favus M, Yates A
Int J Clin Pract Suppl
. 2003 Apr;
101:27-35.
PMID: 12669738
The following article reviews the results of 2 investigational Phase III trials of alendronate. Alendronate has been found to induce clinically significant increases in bone mineral density at the spine,...
10.
Sorensen O, Crawford G, Mulder H, Hosking D, Gennari C, Mellstrom D, et al.
Bone
. 2003 Mar;
32(2):120-6.
PMID: 12633783
Limited placebo-controlled data are available to assess the long-term fracture efficacy of bisphosphonates. In order to determine the effects of 5 years of risedronate treatment, we extended a 3-year, placebo-controlled...